Kohli, P., Waters, D. D., Nemr, R., Arsenault, B. J., Messig, M., DeMicco, D. A., … Kastelein, J. J. P. (2015). Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. J Am Coll Cardiol, 65(4), 402–404. https://doi.org/10.1016/j.jacc.2014.10.053

Kohli, Payal, David D. Waters, Rita Nemr, Benoit J. Arsenault, Michael Messig, David A. DeMicco, Rachel Laskey, and John J. P. Kastelein. “Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL.” J Am Coll Cardiol 65, no. 4 (February 3, 2015): 402–4. https://doi.org/10.1016/j.jacc.2014.10.053.

Kohli P, Waters DD, Nemr R, Arsenault BJ, Messig M, DeMicco DA, et al. Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. J Am Coll Cardiol. 2015 Feb 3;65(4):402–4.

Kohli, Payal, et al. “Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL.” J Am Coll Cardiol, vol. 65, no. 4, Feb. 2015, pp. 402–04. Pubmed, doi:10.1016/j.jacc.2014.10.053.

Kohli P, Waters DD, Nemr R, Arsenault BJ, Messig M, DeMicco DA, Laskey R, Kastelein JJP. Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. J Am Coll Cardiol. 2015 Feb 3;65(4):402–404.